Adel Al-Assy RPh is a seasoned pharmaceutical Revenue cycle, supply chain and procurement expert, currently serving as the Senior Manager of Pharmaceuticals Supply Chain Management at M42 in Abu Dhabi. With over a decade of experience in the healthcare industry, he has a proven track record of optimizing multi-million-dollar budgets, leading large-scale pharmaceutical tenders, and forging strategic partnerships with key industry stakeholders. Adel has also played a pivotal role in collaborating with health authorities to ensure medication availability across various healthcare settings. He holds an EMBA in Healthcare leadership, Bachelor’s degree in Pharmaceutical Sciences from the University of Alexandria and is a certified professional in revenue cycle and supply chain management.
Director of Ambulatory Pharmacy
Cleveland Clinic Abu Dhabi
Ahmad Chaker
R.Ph., EMBA, DPLA, BCSCP
Ahmad Chaker is currently the Director of Ambulatory Pharmacy at Cleveland Clinic Abu Dhabi. Ahmad previously worked in multiple positions at Cleveland Clinic Abu Dhabi: Manager, Oncology Pharmacy Services; Manager, Sterile Preparation Center; Lead Pharmacist Automation; and Informatics. Before joining the Cleveland Clinic in Abu Dhabi, Ahmad worked at Al Mafraq Hospital in Abu Dhabi and The American Hospital in Dubai. He carries multiple certifications in the fields of sterile preparation, automation, project improvement, and leadership. Ahmad’s major areas of interest are process improvement, lean management, change management, sterile preparation compounding, pharmacy informatics, and automation. Ahmad has delivered multiple presentations and posters on sterile preparations, the clean room, automated dispensing cabinets, and pharmacy manpower benchmarks.
Dr. Sara Al Dallal, the founder and president of the Emirates Medical Association’s Emirates Health Economics Society is a Medical Doctor graduated from the UAE University College of Medicine and Health Sciences. She completed her internal medicine residency in Dubai Health Authority, and she holds a master's in health care management from Royal Colleges of Surgeons Ireland and a double master's degree on Health Policy and Health Economics from London School of Economics. She is currently holding the position of Senior Health Service Specialist in Dubai Health Authority.
Zeyad Elgamal is a healthcare leader with over 20 years of experience spanning hospital and retail pharmacy, pharmaceutical industry, healthcare management, and education across three continents. He holds a master's in management from Harvard University and executive training from Harvard Kennedy School. A Pharm.D. graduate from the University of Colorado, he is a Certified Diabetes Educator, SCOPE-certified in obesity management, and holds Additional Prescribing Authority (APA). Zeyad serves as Lead Clinical Pharmacist at Cleveland Clinic Abu Dhabi and lectures at Imperial College London Abu Dhabi, Alameen University, and Alexandria University, contributing to the advancement of diabetes education and clinical practice.
CEO and Founder of both Specia LLC and Paslier Consulting LLC
Dr. Jill Paslier
Dr. Jill Paslier is a specialty pharmacy expert and the CEO and Founder of both Specia LLC and Paslier Consulting LLC. Specia LLC focuses on developing specialty pharmacy workflows and training programs, while Paslier Consulting LLC provides consulting services for specialty pharmacy operations, accreditation, and medication safety. She has provided expertise to organizations such as the Institute for Safe Medication Practices (ISMP), Integral Healthcare Solutions (IHS), and MetaStar.
Dr. Paslier earned her Doctor of Pharmacy (PharmD) from the University of Minnesota College of Pharmacy in 2014 and completed the ISMP International Safe Medication Management Fellowship in 2021. She holds certifications in Medication Safety, Lean Six Sigma Green Belt, Certified Specialty Pharmacist (CSP), and Google Project Management.
CEO and Co-Founder of VantEdge Acces
Illinois, USA
Kasem S Akhras
PharmD
Dr Kasem Akhras is CEO and Co-Founder of VantEdge Access, a healthcare start-up
company bringing over 30 years of global biopharmaceutical experience in Market Access,
pricing, Commercialization and artificial intelligence (AI). He has led strategic access and
Government AMairs functions for top 10 pharma companies and advised on due diligence
for multi-million-dollar deals. Kasem is a published author on Market Access in emerging
markets, rare diseases, and Gene Therapy commercialization. His work bridges strategy,
policy, and data science to expand global access to advanced therapies. He is passionate
about leveraging AI to drive smarter, faster access decisions across diverse healthcare
systems.
JOIN US
DON’T MISS OUT TO REGISTER AND BE A PART IN SHAPING THE FUTURE OF
